BridgeMD
New treatment option for Overactive Bladder Syndrome
Official title Impact of TTNS on Bladder Symptoms Among People With MS, A RCT
ClinicalTrials.gov ID: NCT06341673
What this study is testing
- What it's testing
- Background: Neurogenic lower urinary tract dysfunction is common among people with multiple sclerosis (MS). Recent studies showed that bladder storage symptoms are predominant among MS with a pooled prevalence of frequency at 73.45% followed by urgency at 63.87%.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Ambulatory (with or without assistive device)
- Aged ≥18 years old
- Able to understand spoken and written Arabic Language
- Self-reported with at least one bladder storage symptom such as urinary frequency urinary urgency, nocturia, with or without urge urinary incontinence
- Willing to give written informed consent
You likely can't join if
- People with MS will be excluded if they have one or more of the following criteria at randomization:
- Indwelling urethral catheter
- Indwelling suprapubic catheter
- Bladder malignancy
- Diabetic mellitus
- Pregnant women or plan to be pregnant during the study intervention
See the full eligibility criteria
- Ambulatory (with or without assistive device)
- Aged ≥18 years old
- Able to understand spoken and written Arabic Language
- Self-reported with at least one bladder storage symptom such as urinary frequency urinary urgency, nocturia, with or without urge urinary incontinence
- Willing to give written informed consent
- Able to understand how to complete the study outcome measures
- People with MS will be excluded if they have one or more of the following criteria at randomization:
- Indwelling urethral catheter
- Indwelling suprapubic catheter
- Bladder malignancy
- Diabetic mellitus
- Pregnant women or plan to be pregnant during the study intervention
- Recent pelvic related surgery \<1 year
- Pacemaker or other metallic internal devices
- Urinary tract infections (UTIs) during recruitment phase
- Unable to understand the instructions relating to operating the unit
- Having a bladder BOTOX-injection in the last 12-month
The study team makes the final eligibility decision.
Where it's taking place
- Khobar, Eastern Providence, Saudi Arabia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Khobar, Eastern Providence, Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.